Goldenwell Biotech holds a performance score of 12 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.43, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Goldenwell Biotech will likely underperform. Use Goldenwell Biotech maximum drawdown, as well as the relationship between the rate of daily change and period momentum indicator , to analyze future returns on Goldenwell Biotech.
Risk-Adjusted Performance
Good
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Goldenwell Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile essential indicators, Goldenwell Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Quick Ratio
1.30
Fifty Two Week Low
0.2950
Fifty Two Week High
0.2950
Goldenwell
Goldenwell Biotech Relative Risk vs. Return Landscape
If you would invest 20.00 in Goldenwell Biotech on September 26, 2025 and sell it today you would earn a total of 275.00 from holding Goldenwell Biotech or generate 1375.0% return on investment over 90 days. Goldenwell Biotech is currently generating 13.2702% in daily expected returns and assumes 84.2519% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Goldenwell, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days Goldenwell Biotech is expected to generate 118.31 times more return on investment than the market. However, the company is 118.31 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.
Goldenwell Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Goldenwell Biotech's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Goldenwell Biotech, and traders can use it to determine the average amount a Goldenwell Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1575
Best Portfolio
Best Equity
GWLL
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average Goldenwell Biotech is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Goldenwell Biotech by adding it to a well-diversified portfolio.
Goldenwell Biotech Fundamentals Growth
Goldenwell Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Goldenwell Biotech, and Goldenwell Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Goldenwell Pink Sheet performance.
By examining Goldenwell Biotech's fundamental ratios, stakeholders can obtain critical insights into Goldenwell Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Goldenwell Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company was incorporated in 2019 and is based in Twinsburg, Ohio. Goldenwell Biotech is traded on OTC Exchange in the United States.
Things to note about Goldenwell Biotech performance evaluation
Checking the ongoing alerts about Goldenwell Biotech for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Goldenwell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Goldenwell Biotech is way too risky over 90 days horizon
Goldenwell Biotech appears to be risky and price may revert if volatility continues
Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K.
Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations.
Roughly 63.0% of the company shares are held by company insiders
Evaluating Goldenwell Biotech's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Goldenwell Biotech's pink sheet performance include:
Analyzing Goldenwell Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Goldenwell Biotech's stock is overvalued or undervalued compared to its peers.
Examining Goldenwell Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Goldenwell Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Goldenwell Biotech's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Goldenwell Biotech's pink sheet. These opinions can provide insight into Goldenwell Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Goldenwell Biotech's pink sheet performance is not an exact science, and many factors can impact Goldenwell Biotech's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.